Graham Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1547 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1498 |
|
|
2024
Q3 | – | Sell |
-417,161
| Closed | -$1.07M | – | 1367 |
|
|
2024
Q2 | $1.07M | Buy |
+417,161
| New | +$1.07M | 0.02% | 376 |
|
|
2023
Q4 | – | Sell |
-10,612
| Closed | -$122K | – | 1383 |
|
|
2023
Q3 | $122K | Sell |
10,612
-21,685
| -67% | -$249K | ﹤0.01% | 908 |
|
|
2023
Q2 | $817K | Buy |
+32,297
| New | +$817K | 0.02% | 406 |
|
|
2022
Q2 | – | Sell |
-20,030
| Closed | -$390K | – | 1284 |
|
|
2022
Q1 | $390K | Buy |
+20,030
| New | +$390K | 0.01% | 634 |
|